Fitria S. Wulandari

No. 291, Zhongzheng Road
Chung-ho, TPQ 23561, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Comprehensive In Silico Investigation of L-Glutamine Transporters and Metabolism in Glioblastoma.

Comprehensive In Silico Investigation of L-Glutamine Transporters and Metabolism in Glioblastoma.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 19, 2026

Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma.

Integrin αvβ3 is a Potential Therapeutic Target in Cholangiocarcinoma.

Journal: International journal of medical sciences

Published: September 11, 2025

Multi-Omics and Single-Cell Dissection of Exostosin Glycosyltransferases (EXT1/EXT2) Reveals Divergent Oncogenic Roles and Therapeutic Vulnerabilities in Gliomas.

Multi-Omics and Single-Cell Dissection of Exostosin Glycosyltransferases (EXT1/EXT2) Reveals Divergent Oncogenic Roles and Therapeutic Vulnerabilities in Gliomas.

Journal: Journal of Cancer

Published: August 19, 2025

Multi-Omics and Single-Cell Dissection Reveals EXT1 as a Glycosylation-Linked Therapeutic Target in Cancer.

Multi-Omics and Single-Cell Dissection Reveals EXT1 as a Glycosylation-Linked Therapeutic Target in Cancer.

Journal: Oncology research

Published: July 16, 2025

A machine learning framework using urinary biomarkers for pancreatic ductal adenocarcinoma prediction with post hoc validation via single-cell transcriptomics.

A machine learning framework using urinary biomarkers for pancreatic ductal adenocarcinoma prediction with post hoc validation via single-cell transcriptomics.

Journal: Briefings in bioinformatics

Published: July 16, 2025

Targeting ORMDL2 in glioblastoma through integrated landscape of high-throughput sequencing and pharmacogenomic analysis.

Targeting ORMDL2 in glioblastoma through integrated landscape of high-throughput sequencing and pharmacogenomic analysis.

Journal: International journal of medical sciences

Published: May 05, 2025

Metal ion transporter SLC39A14-mediated ferroptosis and glycosylation modulate the tumor immune microenvironment: pan-cancer multi-omics exploration of therapeutic potential.

Metal ion transporter SLC39A14-mediated ferroptosis and glycosylation modulate the tumor immune microenvironment: pan-cancer multi-omics exploration of therapeutic potential.

Journal: Cancer cell international

Published: April 06, 2025

Multi-omics profiling reveals PLEKHA6 as a modulator of β-catenin signaling and therapeutic vulnerability in lung adenocarcinoma.

Multi-omics profiling reveals PLEKHA6 as a modulator of β-catenin signaling and therapeutic vulnerability in lung adenocarcinoma.

Journal: American journal of cancer research

Published: December 09, 2024

Integration of multi-omics and single-cell transcriptome reveals mitochondrial outer membrane protein-2 (MTX-2) as a prognostic biomarker and characterizes ubiquinone metabolism in lung adenocarcinoma.

Integration of multi-omics and single-cell transcriptome reveals mitochondrial outer membrane protein-2 (MTX-2) as a prognostic biomarker and characterizes ubiquinone metabolism in lung adenocarcinoma.

Journal: Journal of Cancer

Published: November 13, 2024

Comprehensive analysis of bulk and single-cell RNA sequencing data reveals Schlafen-5 (SLFN5) as a novel prognosis and immunity.

Comprehensive analysis of bulk and single-cell RNA sequencing data reveals Schlafen-5 (SLFN5) as a novel prognosis and immunity.

Journal: International journal of medical sciences

Published: May 01, 2024

Showing 1-10 of 10

Last Updated: 09/26/2026